Press Releases
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of...
Press Releases
Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
Bavarian Nordic announced the signing of an agreement with AdaptVac, a joint venture established by ExpreS2ion Biotechnologies and NextGen Vaccines spun out of the...
Clinical Trials
SGS to provide analytical testing for AstraZenecas Covid-19 vaccine
SGS will provide its services to support the development of AstraZeneca’s Covid-19 vaccine candidate – AZD1222 – which was co-invented by the University of...
News
Csafe Global appoints new Latin America director
CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced that Denis Caputo has officially joined the...
News
Hyderabad Airport enhances cold chain with mutli-ULD cool dolly
India’s GMR Hyderabad International Airport (GHIAL) has started using a multi-ULD cool dolly for the transportation of temperature- and time-sensitive shipments such as pharma...
Drug Research
BioInvent’s BI-1206 could improve treatment in several cancers
Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert in immunotherapy showcased the broad potential of BI-1206 in...
Clinical Trials
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read